| 编号 | 化学名称 | Cas号 | 纯度 | 化学结构 |
|---|---|---|---|---|
| 17030116 | Bimiralisib | 1225037-39-7 | 98% | ![]() |
| Bimiralisib,也被称为PQR309,是一种口服生物可用的磷脂- 3 -激酶抑 | ||||
| 17030110 | BEC HCl | 222638-67-7 | 98% | ![]() |
| BEC,也称为S -(2-boronoethyl)-L-cysteine,是一个慢结合和竞争力的精氨酸 | ||||
| 17109003 | BGP-15 | 66611-37-8 | 98% | ![]() |
| BGP-15, 是一种带有PARP抑制活性的烟碱类胺肟衍生物。已经证明BGP- | ||||
| 16122908 | Butylphthalide | 6066-49-5 | 98% | ![]() |
| Butylphthalide, also known as 3-n-butylphthalide or NBP, is an antioxidant and one of | ||||
| 16122907 | Buthionine Sulphoximine | 5072-26-4 | 98% | ![]() |
| Buthionine Sulphoximine, also known as NSC-326231, is a gamma-glutamylcysteine synthe | ||||
| 16122906 | 布瓦西坦 | 357336-20-0 | 98% | ![]() |
| Brivaracetam, also known as UCB 34714, is a chemical analog of levetiracetam, is a ra | ||||
| 16122905 | Brigatinib (AP-26113) | 1197953-54-0 | 98% | ![]() |
| Brigatinib, also known as AP-26113, is an orally active, potent and selective Dual AL | ||||
| 16122904 | Brevianamide F | 38136-70-8 | 98% | ![]() |
| Brevianamide F , also known as cyclo-(L-Trp-L-Pro), belongs to a class of naturally o | ||||
| 16122903 | Bohemine | 189232-42-6 | 98% | ![]() |
| Bohemine is a potent and selective, cell-permeable, cyclin-dependent kinase (CDK) inh | ||||
| 16122902 | BMS-687453 | 1000998-59-3 | 98% | ![]() |
| BMS-687453 is a potent and selective peroxisome proliferator activated receptor (PPAR | ||||
| 16122901 | BML-210 | 537034-17-6 | 98% | ![]() |
| BML-210, also known as CAY10433, is HDAC inhibitor. BML-210 induces growth inhibition | ||||
| 16122868 | BIIB021 | 848695-25-0 | 98% | ![]() |
| BIIB021, also known as CNF2024, is an orally active, purine-scaffold, small-molecule | ||||
| 16122867 | BI605906 | 960293-88-3 | 98% | ![]() |
| BI605906 is a IKK inhibitor. BI605906 inhibits TNF-dependent IB degradation and expre | ||||
| 16122866 | Benzbromarone | 3562-84-3 | 98% | ![]() |
| Benzbromarone is a uricosuric agent and non-competitive inhibitor of xanthine oxidase | ||||
| 16122805 | BAY-59-3074 | 406205-74-1 | 98% | ![]() |
| BAY-59-3074 is a novel cannabinoid CB1/CB2 receptor partial agonist with analgesic pr | ||||
| 16122804 | Batimastat | 130370-60-4 | 98% | ![]() |
| Batimastat (also known as BB-94) is a synthetic matrix metalloproteinase inhibitor th | ||||
| 16122778 | BFH772 | 890128-81-1 | 98% | ![]() |
| BFH772 is a novel potent oral VEGFR2 inhibitor, targeting VEGFR2 kinase with IC50 of | ||||
| 16122776 | BI-78D3 | 883065-90-5 | 98% | ![]() |
| BI-78D3 is a competitive JNK inhibitor with IC50 of 280nM that displays > 100 fold | ||||
| 16122769 | BDA-366 | 1909226-00-1 | 98% | ![]() |
| BDA-366 is a small-molecule Bcl2-BH4 domain antagonist and binds BH4 with high affini | ||||
| 16122742 | BI-7273 | 1883429-21-7 | 98% | ![]() |
| BI-7273 is a potent, selective, and cell-permeable BRD9 BD Inhibitor. | ||||
| 16122740 | BI-9564 | 1883429-22-8 | 98% | ![]() |
| BI-9564 is a selective inhibitor of BRD9 and BRD7 bromodomains with the IC50 of 75 nM | ||||
| 16122733 | BAW2881 (NVP-BAW2881) | 861875-60-7 | 98% | ![]() |
| BAW2881 (NVP-BAW2881) is a novel vascular endothelial growth factor (VEGF) receptor t | ||||
| 6111507 | BMS-983970 | 1584713-87-0 | 98% | ![]() |
| BMS-983970 is an oral pan-Notch inhibitor for the treatment of cancer. | ||||
| 6111415 | BAY-61-3606 | 648903-57-5 | 98% | ![]() |
| BAY-61-3606 is a potent and selective inhibitor of Syk kinase (Ki = 7.5 nM). | ||||
| 61402 | BH3I-1 | 300817-68-9 | 98% | ![]() |
| BH3I-1 is an inhibitor of Bcl-xL with IC 50 of 293.95 M. BH3I-1 is a cell permeable B | ||||
| 61401 | Bax inhibitor peptide V5 | 579492-81-2 | 98% | ![]() |
| Bax inhibitor peptide V5 is a peptide inhibitor of Bax translocation to mitochondria. | ||||
| 61122 | BMS-986020 | 1257213-50-5 | 98% | ![]() |
| BMS-986020 is a lysophosphatidic acid 1 receptor antagonist. BMS-986020 is in Phase 2 | ||||
| 6111106 | (±)-Bisoprolol hemifumarate | 104344-23-2 | 98% | ![]() |
| Bisoprolol is a selective type 1 adrenergic receptor blocker.Bisoprolol, on beta 1-ad | ||||
| 6111023 | BNC105 | 945771-74-4 | 98% | ![]() |
| BNC105 is a tubulin polymerization inhibitor with potent antiproliferative and tumor | ||||
| 6111002 | 6-bromo-[1,2,4]triazolo[1,5-a]pyridine | 356560-80-0 | 98% | ![]() |
| 6-bromo-[1,2,4]triazolo[1,5-a]pyridine | ||||
